{"id":"W4417021721","doi":"10.1182/blood-2025-3795","title":"The activin receptor-like kinase-2 inhibitor zilurgisertib (INCB000928) as monotherapy or with ruxolitinib in patients with anemia due to myelofibrosis: Phase 1/2 study final results","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Anemia; Pharmacokinetics; Hepcidin; Phases of clinical research; Regimen; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00158278,0.00118607,0.001549929,0.0003316073,0.0002473133,0.0009934041,0.0008057511,0.001104523,0.003969597],"category_scores_gemma":[0.0007948712,0.0004813927,0.001341088,0.0003537581,0.0005465741,0.000685921,0.0002962501,0.003399101,0.000843176],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009206776,"about_ca_system_score_gemma":0.001519566,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009950972,"about_ca_topic_score_gemma":0.00425812,"domain_scores_codex":[0.9996752,0.000143835,0.00002043794,0.00005782701,0.00004082569,0.00006184297],"domain_scores_gemma":[0.9994947,0.0000872034,0.0001089085,0.00003427018,0.00005428719,0.0002205812],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6416791,0.06010881,0.008272327,0.00241922,0.003410897,0.0003920951,0.0002950641,0.003083846,0.08983488,0.000459465,0.01183347,0.1782109],"study_design_scores_gemma":[0.6372288,0.3334477,0.01396569,0.0001172187,0.001415423,0.0004598904,0.00006220536,0.001410379,0.005999841,0.00027472,0.005573432,0.00004462374],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9776955,0.005830613,0.001320398,0.001095414,0.0001832092,0.005069073,0.004544193,0.0002595567,0.00400204],"genre_scores_gemma":[0.9758448,0.00389051,0.004082482,0.001800844,0.0001883043,0.003828253,0.006627505,0.00006700048,0.003670259],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003969597,"threshold_uncertainty_score":0.01327968,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01242850655876685,"score_gpt":0.2869146319855738,"score_spread":0.2744861254268069,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}